MedPath

Effect of Crataegus Monogyna in hypertension and associated sleep disorder

Phase 3
Recruiting
Conditions
Hypertension.
Essential (primary) hypertension
Registration Number
IRCT20180225038859N1
Lead Sponsor
Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Hypertensive patient that they didn't respond to medical treatment

Exclusion Criteria

Pregnancy
Breast feeding
Malignancy
Sever hypertension
Chronic Inflamatory diseas
Renal failure
Sever liver disease
Acute infectious disease
Secondary hypertension
Age less than 35 and older than 60
Taking digoxin
Arryhthmia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of sleep in the Pittsburgh Questionnaire. Timepoint: Measure the quality of sleep at the beginning of study(before intervention)and two week after taking the Crataegus Monogyna. Method of measurement: Pittsburgh sleep quality questionnaire in patients with hypertension.;Systolic blood pressure. Timepoint: Measure the Blood Pressure at the beginning of study(before intervention)and two week after taking the Crataegus Monogyna. Method of measurement: Blood Pressure Device.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath